scholarly journals Reference Renal Artery Diameter Is a Stronger Predictor of Contrast-Induced Nephropathy than Chronic Kidney Disease in Patients with High Cardiovascular Risk

Nephron Extra ◽  
2011 ◽  
Vol 1 (1) ◽  
pp. 38-44 ◽  
Author(s):  
Luca Zanoli ◽  
Stefania Rastelli ◽  
Carmelita Marcantoni ◽  
Julien Blanco ◽  
Davide Capodanno ◽  
...  
2017 ◽  
Vol 16 (1) ◽  
pp. 65-73 ◽  
Author(s):  
G. Ocak ◽  
M. B. Rookmaaker ◽  
A. Algra ◽  
G. J. de Borst ◽  
P. A. Doevendans ◽  
...  

2011 ◽  
Vol 18 (3) ◽  
pp. 224-230 ◽  
Author(s):  
Hao Liu ◽  
Hong Shi ◽  
Jinming Yu ◽  
Fang Chen ◽  
Qingwu Jiang ◽  
...  

2013 ◽  
Vol 19 (1) ◽  
pp. 1-8
Author(s):  
Laurynas Rimševičius ◽  
Diana Aksionova ◽  
Marius Miglinas ◽  
Jolita Badarienė ◽  
Ligita Ryliškytė ◽  
...  

SummaryIncreased awareness of chronic kidney disease stimulates an interest towards early detection and prevention. The true prevalence of kidney injury varies from 10 to 40%, mostly depending on the methodology of the study and the population enrolled. A screening strategy targeting the highest risk groups, those with diabetes or hypertension, family history of diabetes, hypertension, or kidney disease, is likely to be most efficient and cost effective. Quantification for albuminuria should be performed using laboratorymethods or albumin to creatinine ratio and should be monitored at regular intervals. The most correct equations calculating glomerular filtration rate differ in separate populations, and the most accurate equations in patients with high cardiovascular risk are MDRD and CKD-EPI. Markers of early kidney damage have association with other target organs damage, even in subclinical or preclinical mode. Individuals at stage 4 and 5 chronic kidney disease, with higher levels of proteinuria, proteinuria together with haematuria, rapidly declining glomerular filtration rate, or poorly controlled hypertension should be referred to a nephrologist in order to identify the cause, provide recommendations, slow progression, or treat complications.


2014 ◽  
Vol 21 (3) ◽  
pp. 185-191 ◽  
Author(s):  
Mirela - Nicoleta Tudor ◽  
Adina Mitrea ◽  
Simona Georgiana Popa ◽  
Sorin Zaharie ◽  
Maria Moţa ◽  
...  

AbstractBackground and aims. Dyslipidemia (DLP) is a common complication of chronic kidney disease (CKD) and may accelerate its progression. Circulating lipoproteins and their constituent proteins, apolipoproteins, are risk factors for CKD and cardiovascular diseases (CVD). The aim of the study was to determine whether there is a correlation between apolipoproteins and estimated glomerular filtration rate (eGFR) or between apolipoproteins and anthropometrical and laboratory parameters or between evaluated cardiovascular risk (CV) and dyslipidemia/CKD. Material and methods. We performed a study on 51 subjects from the Nephrology Department of Emergency Clinical County Hospital of Craiova, from November 2011 to July 2013. Results. We found statistically significant correlations between eGFR and Apo A1. Also we found a linear correlation between C-reactive protein (CRP) and Apo B. When we evaluated the CV risk using CRP, we found statistically significant differences between the groups (CKD and DLP, only CKD, only DLP and control group), patients with CKD and DLP showing the highest levels of CRP. Conclusions. Elevated levels of Apo A1 are associated with a low rate of CKD. DLP and chronic inflammation play an important role in the progression of CKD. Patients with CKD and DLP had a high cardiovascular risk.


2013 ◽  
Vol 32 (4) ◽  
pp. 606-612 ◽  
Author(s):  
Andrés Díaz-López ◽  
Mònica Bulló ◽  
Josep Basora ◽  
Miguel Ángel Martínez-González ◽  
Marta Guasch-Ferré ◽  
...  

2016 ◽  
Vol 6 (5) ◽  
Author(s):  
Coronado Jorge ◽  
Toro Keyner ◽  
Lujan Marco ◽  
Duitama Jessica ◽  
Pájaro Luis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document